REGENFLEX BIO-PLUS 75mg/3ml

CROSS-LINKED & LINEAR INTERCALATED HYALURONIC ACID

Regenflex BIO-PLUS is a transparent gel based on cross-linked and linear intercalated Hyaluronic acid, created with an advanced and patented technological process.
The aim of this intra-articular injectable is to prevent or to reduce pain, restoring the normal damping and lubricating function of the joint.
Not only will the joint function improve, but the patient will also experience an improvement in their quality of life.

REGENFLEX BIO-PLUS 75mg/3ml

• VISCO-SUPPLEMENTATION HIGH MOLECULAR FRACTION (HA 1 M DALTON + HA 2 M DALTON)
• VISCO-INDUCTION LOW MOLECULAR FRACTION (HA 500 K DALTON)
• REGULATES THE ACTION OF MACROPHAGES
• NORMALISES THE METALLOPROTEASE
• STIMULATES THE SYNOVIOCYTES TO PRODUCE ENDOGENOUS HYALURONIC ACID
• HAS AN ANALGESIC EFFECT BY OCCUPYING THE CD42 SITES (pain receptors)
• RESTORATION OF THE CARTILAGE
  THE 500 THOUSAND DALTON MOLECULAR FRACTION STIMULATES
• LONG PRESENCE INSIDE THE ARTICULAR CHAMBER
• GRADUAL RELEASE OF THE HA WITH MW 500 KDALTON

The matter of weight: 2 molecular fractions

The action of the Hyaluronic acid depends on its molecular weight. The weight, in fact, influences the quantity of exogenous hyaluronic acid that can penetrate the synovial membrane: such quantity is proportionally inverse to the molecular weight itself. The close combination of the cross-linked and the intercalated linear Hyaluronic acid, makes it possible to inject two molecular fractions.

Regenflex BIO-PLUS e BIORIVOLUMETRIA

BIORIVOLUMETRIA is an innovative concept in the field of HYALURONIC ACID-based injectiable medical devices.

The same product makes it possible to simultaneously: restore the volume of the joint chamber by injecting CROSS-LINKED HYALURONIC ACID, and to stimulate receptors of the synoviocytes and chondrocytes thanks to the gradually released linear fraction of the INTERCALATED HA.

Manufacturing technology and functioning

The manufacturing technology used to produce Regenflex BIO-PLUS is the one used for BIORIVOLUMETRIA.
The Biorivolumetria products are MONO-PHASE GELS obtained through a long-lasting cross-linking process at low temperature, the “gentle cross-linking”. The slow mixing allows for the cross-linking agent (BDDE) to widespread in a better and more uniform way. The amount of BDDE used is 30 per cent lower than in the majority of other products with equal degree of viscosity currently on the market.

For the manufacturing of Regenflex BIO-PLUS three molecular weights of Hyaluronic Acid are used: 1 M, 2 M and 500 THOUSAND Dalton. The latter is linear and intercalated and represent 10 per cent of the total Hyaluronic Acid. Differently long chains of HA help to better calibrate the product’s viscosity. The linear Hyaluronic Acid is released gradually in time, performing a prolonged biological action (visco-induction).